S Stanley Plotkin recalls a night in 1957, during his pediatrics internship, when a father brought a gravely ill toddler into ...

While current flu shots need to be updated each season, scientists are finding new ways to make vaccine that could last much longer and cover more strains.

A challenging public health policy landscape under health secretary Robert F. Kennedy has vaccine makers rethinking developing for the U.S. market.

Platform-enabled vaccine design unlocks safer, more effective solutions with outer-membrane vesicles (OMVs) emerging as next-generation technology.

Wits University says it is developing its own engineered virus-like particle systems to boost vaccine production in South Africa and beyond.

Q4 2025 Earnings Call March 3, 2026 4:30 PM ESTCompany ParticipantsPatrick Soon-Shiong - Founder, Executive Chairman and ...

This article explores multiplexing applications in biopharma and highlights key assay development factors to consider.

A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.

Vector-borne diseases (VBDs) represent a critical challenge in infectious disease control due to their complex transmission dynamics, diverse vector ...

Religious exemptions are driving the number of vaccinated NJ kids down to the lowest number in years, causing officials to worry about disease spread.

CD Bioparticles launches comprehensive OMV-Based Bacterial Vaccines Development services for infectious disease and oncology research. NEW YORK, NY, UNITED STATES ...

Hantaviruses, transmitted from rodents to people, have a death rate approaching 40%. They're found around the world, and because there are no approved vaccines or treatments, they're among the ...